Codexis Inc (CDXS.OQ)
CDXS.OQ on NASDAQ Stock Exchange Global Select Market
2.51USD
1 Aug 2013
2.51USD
1 Aug 2013
Price Change (% chg)
$0.06 (+2.45%)
$0.06 (+2.45%)
Prev Close
$2.45
$2.45
Open
$2.49
$2.49
Day's High
$2.51
$2.51
Day's Low
$2.47
$2.47
Volume
1,800
1,800
Avg. Vol
67,900
67,900
52-wk High
$3.78
$3.78
52-wk Low
$2.00
$2.00
About
Codexis, Inc. provides biocatalyst and fermentation processes and products. The Company provides its customers research and development services, biocatalysts and fermentation strains, synthetic and natural products. It is a subsidiary of publicly-traded Maxygen. Codexis uses the Molecular Breeding platform to develop enzymes... (more)
Overall
| Beta: | -- |
| Market Cap (Mil.): | $93.16 |
| Shares Outstanding (Mil.): | 38.03 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CDXS.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -0.88 | -- | -- |
| ROI: | -37.23 | -2.58 | 18.76 |
| ROE: | -39.51 | -2.66 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Verenium Corp (VRNM.OQ) | $2.40 | +0.22 |
| E I Du Pont De Nemours And Co (DD.N) | $58.46 | +0.77 |
| E I Du Pont De Nemours And Co (DD_pa.N) | $85.36 | +0.34 |
| E I Du Pont De Nemours And Co (DD_pb.N) | $94.01 | -0.25 |
| Merck & Co., Inc. (MRK.N) | $48.06 | -0.11 |
| Pfizer Inc. (PFE.N) | $29.15 | -0.08 |
| Teva Pharmaceutical Industries Limited (TEVA.TA) | 13,920.00₪ | -200.00 |
| BASF SE (BASFn.DE) | €67.48 | +0.82 |
| Lonza Group AG (LONN.VX) | CHF71.20 | -0.35 |
| Novozymes A/S (NZYMb.CO) | kr.196.70 | +4.60 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

